Wed, July 11, 2018
Tue, July 10, 2018
Mon, July 9, 2018
Fri, July 6, 2018
Thu, July 5, 2018
Tue, July 3, 2018
Mon, July 2, 2018
Fri, June 29, 2018
Thu, June 28, 2018
Wed, June 27, 2018
Tue, June 26, 2018
Mon, June 25, 2018
Fri, June 22, 2018
Thu, June 21, 2018
Wed, June 20, 2018
Tue, June 19, 2018
Mon, June 18, 2018
Fri, June 15, 2018
Thu, June 14, 2018
Wed, June 13, 2018

Adam Walsh Initiated (ASND) at Strong Buy and Held Target at $85 on, Jun 26th, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-85-on-jun-26th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Adam Walsh of Stifel, Initiated "Ascendis Pharma A/S" (ASND) at Strong Buy and Held Target at $85 on, Jun 26th, 2018.

Adam has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Adam's Rating of Hold.



This is the rating of the analyst that currently disagrees with Adam


  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $78 on, Tuesday, March 20th, 2018